Healthy volunteer study for a liver cancer blood marker
Part of Cancer, Infections clinical trials.
This study looks for a new marker in the blood that might help detect liver cancer in people with hepatitis B. It compares healthy people with those who have hepatitis B and liver cancer, so we need healthy volunteers to serve as a comparison group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You're generally healthy and do not have any tumors anywhere in your body, including the liver or blood.
- You don't have any benign (non-cancerous) liver conditions.
- You don't have any active inflammatory diseases (like infections or autoimmune conditions).
- Your liver, kidney, and heart function tests are normal.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study looks at whether certain blood markers can predict how well the combination of atezolizumab and bevacizumab works for people with advanced liver cancer. It aims to find out if these markers can help guide treatment decisions.
This research study evaluates people with liver disease or at risk for liver disease, and compares them with healthy volunteers. The goal is to better understand liver disease and improve how doctors diagnose and treat it.
This study is looking at a new way to find liver cancer by testing blood and tissue samples. It compares people with liver cancer to people with liver scarring (cirrhosis) but no cancer.
Hear when a new HCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.